Mean % of 5-year survival | % Delta (Pred-Obs) | ||||
---|---|---|---|---|---|
Number | % | AOL predicted | YTR observed (95% CI) | ||
All patients | 666 | 100 | 77.07 | 79.73 (76.47, 82.59) | −2.66 |
Age | |||||
< 50 | 107 | 16.1 | 83.31* | 91.59 (84.46, 95.53) | −8.28 |
50-59 | 148 | 22.2 | 80.61 | 83.78 (76.79, 88.82) | −3.17 |
60-69 | 227 | 34.1 | 78.34 | 80.17 (74.37, 84.8) | −1.83 |
≥ 70 | 184 | 27.6 | 69.03 | 69.01 (61.78, 75.15) | 0.02 |
Sex | |||||
Male | 400 | 60.1 | 76.19 | 78.75 (74.41, 82.44) | −2.56 |
Female | 266 | 39.4 | 78.40 | 81.2 (75.97, 85.41) | −2.8 |
T stage | |||||
T1 | 79 | 11.9 | 91.08 | 94.94 (87.07, 98.07) | −3.86 |
T2 | 117 | 17.5 | 85.76 | 83.76 (75.73, 89.32) | 2 |
T3 | 456 | 68.5 | 72.83 | 76.97 (72.82, 80.57) | −4.14 |
T4 | 14 | 2.1 | 63.57 | 50 (22.86, 72.21) | 13.57 |
Number of positive nodes | |||||
0 | 501 | 75.2 | 83.92 | 84.83 (81.38, 87.69) | −0.91 |
1-3 | 111 | 16.7 | 62.65 | 67.56 (57.99, 75.4) | −4.91 |
4-10 | 47 | 7.1 | 46.79 | 59.57 (44.21, 71.99) | −12.78 |
> 10 | 7 | 1.0 | 19.00 | 42.86 (9.78, 73.44) | −23.86 |
Number of examined nodes | |||||
1-3 | 27 | 4.1 | 85.56 | 88.89 (69.39, 96.27) | −3.33 |
4-10 | 122 | 18.3 | 78.75 | 72.13 (63.26, 79.21) | 6.62 |
> 10 | 517 | 77.6 | 76.23* | 81.04 (77.39, 84.17) | −4.81 |
Histologic grade | |||||
1 | 110 | 16.5 | 81.67 | 82.73 (74.27, 88.62) | −1.06 |
2 | 455 | 68.3 | 75.77 | 78.9 (74.85, 82.37) | −3.13 |
3 | 32 | 4.8 | 72.59 | 81.25 (62.95, 91.11) | −8.66 |
Undefined | 69 | 10.4 | 80.38 | 79.71 (68.16, 87.45) | 0.67 |